Literature DB >> 1531945

Estimation of the potency of ORG 9426 using two different modes of nerve stimulation.

R A Cooper1, R K Mirakhur, P Elliott, G J McCarthy.   

Abstract

The potency of ORG 9426, a new nondepolarising muscle relaxant, has been estimated using two different modes of nerve stimulation in patients anaesthetised with thiopentone, nitrous oxide-oxygen and intravenous fentanyl. The force of contraction of adductor pollicis was measured following a single twitch (ST) at 0.1 Hz or a train-of-four (TOF) mode of stimulation at 2 Hz every ten seconds. Dose-response curves were constructed using a single-dose method. The ED50, ED90 and ED95 were 147,272 and 305 micrograms.kg-1 respectively using the ST mode and 125,230 and 257 micrograms.kg-1 using the TOF mode of stimulation. The ED50S were not significantly different but the differences between ED90S and ED95S were significant (P less than 0.05) indicating greater sensitivity of the neuromuscular junction using TOF stimulation. The results of this study suggest that the information obtained by single-twitch stimulation is not the same as that obtained from the first response of the TOF stimulation, suggesting apparently increased sensitivity (and apparently greater potency) with the TOF mode of stimulation. Org 9426 appears to be a drug with relatively low potency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531945     DOI: 10.1007/BF03008644

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  12 in total

1.  Does clinical anesthesia need new neuromuscular blocking agents?

Authors:  J J Savarese; R J Kitz
Journal:  Anesthesiology       Date:  1975-03       Impact factor: 7.892

2.  Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations.

Authors:  A W Muir; J Houston; K L Green; R J Marshall; W C Bowman; I G Marshall
Journal:  Br J Anaesth       Date:  1989-10       Impact factor: 9.166

3.  Onset and recovery of atracurium and suxamethonium-induced neuromuscular blockade with simultaneous train-of-four and single twitch stimulation.

Authors:  M J Curran; F Donati; D R Bevan
Journal:  Br J Anaesth       Date:  1987-08       Impact factor: 9.166

4.  Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium.

Authors:  F M Gibson; R K Mirakhur; R S Clarke; G G Lavery
Journal:  Br J Anaesth       Date:  1985-11       Impact factor: 9.166

5.  Potency of atracurium: a comparison of single dose and cumulative dose techniques.

Authors:  F M Gibson; R K Mirakhur; G G Lavery; R S Clarke
Journal:  Anesthesiology       Date:  1985-05       Impact factor: 7.892

6.  Neuromuscular pharmacology. A clinical update and commentary.

Authors:  C Lee; R L Katz
Journal:  Br J Anaesth       Date:  1980-02       Impact factor: 9.166

Review 7.  Suxamethonium.

Authors:  N N Durant; R L Katz
Journal:  Br J Anaesth       Date:  1982-02       Impact factor: 9.166

8.  Evaluation of atracurium in anaesthetized man.

Authors:  J P Payne; R Hughes
Journal:  Br J Anaesth       Date:  1981-01       Impact factor: 9.166

9.  Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.

Authors:  J M Wierda; A P de Wit; K Kuizenga; S Agoston
Journal:  Br J Anaesth       Date:  1990-04       Impact factor: 9.166

10.  Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat.

Authors:  W C Bowman; I W Rodger; J Houston; R J Marshall; I McIndewar
Journal:  Anesthesiology       Date:  1988-07       Impact factor: 7.892

View more
  12 in total

1.  The effect of single twitch and train-of-four stimulation on twitch forces during stable neuromuscular block.

Authors:  G van Santen; V Fidler; M C Houwertjes; W M Top; J M Wierda
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 2.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

3.  Positive and negative staircase effect during single twitch and train-of-four stimulation: a laboratory study in dogs.

Authors:  Manuel Martin-Flores; Chia T Tseng; Daniel M Sakai; Marta Romano; Luis Campoy; Robin D Gleed
Journal:  J Clin Monit Comput       Date:  2016-02-16       Impact factor: 2.502

Review 4.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

6.  Different priming techniques, including mivacurium, accelerate the onset of rocuronium.

Authors:  M Naguib
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

7.  Stabilization of the neuromuscular response when switching between different modes of nerve stimulation at surgical degrees of neuromuscular blockade.

Authors:  H Kirkegaard-Nielsen; H S Helbo-Hansen; P Lindholm; I Krogh Severinsen; K Bülow; E W Jensen
Journal:  J Clin Monit       Date:  1995-09

8.  Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium.

Authors:  E P McCoy; V R Maddineni; P Elliott; R K Mirakhur; I W Carson; R A Cooper
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

Review 9.  Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.

Authors:  R K Mirakhur
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

10.  Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis.

Authors:  C Beauvoir; P Peray; J P Daures; J L Peschaud; F D'Athis
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.